BioCentury
ARTICLE | Clinical News

HA-Irinotecan: Phase III ongoing

November 19, 2012 8:00 AM UTC

Alchemia said an independent DSMB for a second time recommended continuation of the double-blind, international Phase III ACO002 trial of HA-Irinotecan after a review of data from 220 patients found n...